Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

acetylcholinesterase inhibitors (Alzheimer's disease)

Home Drugsacetylcholinesterase inhibitors (Alzheimer's disease)

acetylcholinesterase inhibitors (Alzheimer's disease)

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Acetylcholinesterase Inhibitors and leuprolide acetate for the treatment of Alzheimer's disease
Applicant: VOYAGER PHARMACEUTICAL CORPPriority: 2005
EP
US
4 publications
Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer's disease
Applicant: GIL ANA MPriority: 2002
US
Substituted 1, 2, 3, 4-tetrahydroquinolin-7-yl carbamates as acetylcholinesterase inhibitors for treatment of Alzheimer's disease
Applicant: ROY KULDEEP KUMARPriority: 2011
US
2 publications
Treatment of Alzheimer's Disease and Mild Cognitive impairment using GnRH-I analogs and one or more of acetylcholinesterase inhibitors and NMDA receptor antagonists
Applicant: GREGORY CHRISTOPHER WPriority: 2007
US
2 publications
Abeta42 lowering agents
Applicant: UNIV CALIFORNIAPriority: 2000
US
WO
8 publications
Method of reducing Abeta42 and treating diseases
Applicant: UNIV CALIFORNIAPriority: 2005
US
METHOD OF REDUCING ABETA42 AND TREATING DISEASES
Applicant: MAYO FOUNDATIONPriority: 2007
US
5-HT4 receptor agonist compounds for treatment of cognitive disorders
Applicant: BEATTIE DAVIDPriority: 2009
CN
US
5 publications